Gene Therapy Research

Introduction

Takehide Murataa,*, Jianzhi Pana (c), Megumi Hirosea, Kumiko Inabea, Yukari Kujimea, Chitose Kuriharaa, Yuka Kusaa, Satoko Masuzakia, Koji Nakadea, Yuri Nakanoa, Masato Ohkuboa, Takahito Yamasakia, Yuichi Obatab, Kazunari K. Yokoyamaa (d)

Dr. Tremblay’s laboratory contributes to the development of treatments for Duchenne muscular dystrophy (DMD). We have an extensive expertise in cell transplantation, histology, immunohistology, immunology and gene therapy. We principally focus on the transplantation of normal or genetically modified Muscle Precursor Cells (MPCs) into muscles to restore the dystrophin.

Hua Su, Assistant Professor, Center for Cerebral Vascular Research, Department of Anesthesia and Perioperative, University of California, San Francisco

My current researches are focused on developing strategies for angiogenic gene and and cell Therapies for myocardial infarction and ischemic brain injuries.